Fulcrum Therapeutics FULC
NASDAQ FULC
$3.85 +0.01 (+0.26%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026)

Fulcrum Therapeutics (FULC) posted quarterly Prepaid Assets of $4.0 million for Q2 2026, down 23.77% year-over-year from $5.3 million in Q2 2025, and down 25.07% quarter-over-quarter from $5.4 million in Q1 2026.

Analysis

Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026) Analysis & Trends

Fulcrum Therapeutics (FULC) has reported Prepaid Assets for 9 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Prepaid Assets fell 23.77% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (down 23.77% YoY), while the FY2025 annual figure was $5.2 million, down 23.98% from the prior year.
  • Prepaid Assets eased to $4.0 million in Q2 2026 per FULC's latest filing, from $5.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $6.8 million in Q4 2024 and bottomed at $4.0 million in Q2 2026.
  • Historically, Prepaid Assets has averaged $5.0 million across 5 years, with a median of $4.9 million in 2023.
  • Annual changes were most pronounced in 2022 — Prepaid Assets soared 81.16% — and 2025, when it retreated 23.98%.
  • Fulcrum Therapeutics' Prepaid Assets stood at $4.4 million in 2022, then gained by 24.54% to $5.4 million in 2023, then increased by 25.09% to $6.8 million in 2024, then declined by 23.98% to $5.2 million in 2025, then dropped by 22.48% to $4.0 million in 2026.
  • Business Quant data shows FULC's Prepaid Assets at $4.0 million in Q2 2026, $5.4 million in Q1 2026, and $5.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Fulcrum Therapeutics 293.24 Mn 293.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.01 Mn
Mar 31, 2026 5.35 Mn
Dec 31, 2025 5.17 Mn
Sep 30, 2025 5.22 Mn
Jun 30, 2025 5.26 Mn
Mar 31, 2025 4.97 Mn
Dec 31, 2024 6.81 Mn
Sep 30, 2024 6.60 Mn
Jun 30, 2024 4.18 Mn
Mar 31, 2024 4.64 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 4.82 Mn
Jun 30, 2023 4.13 Mn
Mar 31, 2023 4.89 Mn
Dec 31, 2022 4.37 Mn
Sep 30, 2022 5.14 Mn
Jun 30, 2022 4.17 Mn
Mar 31, 2022 4.15 Mn
Dec 31, 2021 4.20 Mn
Sep 30, 2021 4.67 Mn